NCT05156437View on ClinicalTrials.gov

Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 16, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Endocarditis
Interventions
DRUG

Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin

Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin

DRUG

Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline

Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline

Trial Locations (1)

26506

WVU Heart and Vascular Institute, Morgantown

All Listed Sponsors
lead

Vinay Badhwar

OTHER